BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7644715)

  • 21. Prospective study of talc use and ovarian cancer.
    Gertig DM; Hunter DJ; Cramer DW; Colditz GA; Speizer FE; Willett WC; Hankinson SE
    J Natl Cancer Inst; 2000 Feb; 92(3):249-52. PubMed ID: 10655442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
    Wentzensen N; O'Brien KM
    Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migration of Talc From the Perineum to Multiple Pelvic Organ Sites.
    McDonald SA; Fan Y; Welch WR; Cramer DW; Godleski JJ
    Am J Clin Pathol; 2019 Oct; 152(5):590-607. PubMed ID: 31305893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological effects of cosmetic talc.
    Wehner AP
    Food Chem Toxicol; 1994 Dec; 32(12):1173-84. PubMed ID: 7813991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Penninkilampi R; Eslick GD
    Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: "Perineal powder exposure and the risk of ovarian cancer".
    Muscat JE; Wynder EL
    Am J Epidemiol; 1997 Nov; 146(9):786. PubMed ID: 9366627
    [No Abstract]   [Full Text] [Related]  

  • 28. Genital talc exposure and risk of ovarian cancer.
    Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
    Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer and talc: a case-control study.
    Cramer DW; Welch WR; Scully RE; Wojciechowski CA
    Cancer; 1982 Jul; 50(2):372-6. PubMed ID: 7083145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perineal powder use and risk of ovarian cancer.
    Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc.
    Harlow BL; Weiss NS
    Am J Epidemiol; 1989 Aug; 130(2):390-4. PubMed ID: 2750733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and risk assessment for ovarian cancer.
    Daly M; Obrams GI
    Semin Oncol; 1998 Jun; 25(3):255-64. PubMed ID: 9633839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between perineal cosmetic talc usage and ovarian talc particle burden.
    Heller DS; Westhoff C; Gordon RE; Katz N
    Am J Obstet Gynecol; 1996 May; 174(5):1507-10. PubMed ID: 9065120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Talc powder and ovarian cancer: what is the evidence?
    Micha JP; Rettenmaier MA; Bohart R; Goldstein BH
    Arch Gynecol Obstet; 2022 Oct; 306(4):931-933. PubMed ID: 35348830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Talc: need we beware?
    Natow AJ
    Cutis; 1986 May; 37(5):328-9. PubMed ID: 3754807
    [No Abstract]   [Full Text] [Related]  

  • 36. Asbestos exposure and ovarian fiber burden.
    Heller DS; Gordon RE; Westhoff C; Gerber S
    Am J Ind Med; 1996 May; 29(5):435-9. PubMed ID: 8732916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Talc and ovarian cancer.
    Narod SA
    Gynecol Oncol; 2016 Jun; 141(3):410-412. PubMed ID: 27095190
    [No Abstract]   [Full Text] [Related]  

  • 38. Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders-A Case Series.
    Steffen JE; Tran T; Yimam M; Clancy KM; Bird TB; Rigler M; Longo W; Egilman DS
    J Occup Environ Med; 2020 Feb; 62(2):e65-e77. PubMed ID: 31868762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perineal powder exposure and the risk of ovarian cancer.
    Cook LS; Kamb ML; Weiss NS
    Am J Epidemiol; 1997 Mar; 145(5):459-65. PubMed ID: 9048520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.